N#CC(NNC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1nc2cc(C(=O)c3ccccc3)ccc2[nH]1)c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?